AbbVie Inc. against Gilead Sciences — live side-by-side technical comparison.
Prices as of 2026-11-09T21:03:43+00:00 UTC · updates daily
GILD leads 5 of the 7 windows we measure — over 1 month ABBV is +6.1% and GILD +12.0%; over year to date ABBV is +28.4% and GILD +38.0%. The ABBV/GILD price ratio stands at 1.7322, below its 50-day average of 1.7774, and above the 200-day average of 1.6975. A ratio above its own average means ABBV is gaining on GILD; on this reading the recent edge belongs to GILD.
Compare ABBV and GILD: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| ABBV | GILD | |
|---|---|---|
| Price | $293.30 | $169.32 |
| 1 day | +0.7% | +1.5%lead |
| 5 days | +1.5%lead | -0.6% |
| 1 month | +6.1% | +12.0%lead |
| 6 months | +45.5%lead | +28.9% |
| Year to date | +28.4% | +38.0%lead |
| 1 year | +33.8% | +42.5%lead |
| 2 years | +47.0% | +75.3%lead |
| 52-week position | 91% of range | 88% of range |
| 52-week range | $190.75–$302.93 | $116.88–$176.58 |
| vs 50-day average | above $272.70 | above $153.51 |
| vs 200-day average | above $239.31 | above $141.13 |
| RSI (14) | 61 | 63 |
| Market cap | $514.9B | $207.0B |
| Analyst target | $310.65 (+6.6%) | $174.77 (+4.7%) |
| Analysts | 26 | 26 |
| Consensus | Buy | Buy |
| Next earnings | Oct 30, 2026 | Oct 29, 2026 |
ABBV trades at $293.30, above its 50-day average of $272.70, and above the 200-day at $239.31. It sits at 91% of its 52-week range ($190.75–$302.93); 14-day RSI is 61, in neutral territory; an average session moves it about 2.6%. For levels, the first level overhead is $294.89 (0.5% away) and the first support below is $275.00 (6.2% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
GILD trades at $169.32, above its 50-day average of $153.51, and above the 200-day at $141.13. It sits at 88% of its 52-week range ($116.88–$176.58); 14-day RSI is 63, in neutral territory; an average session moves it about 3.2%. For levels, the first level overhead is $174.48 (3.0% away) and the first support below is $153.51 (9.3% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
GILD is the more volatile of the two — an average session moves it 3.2% against 2.6% for ABBV, so an identical position size carries roughly 1.2× the daily risk.
The comparison turns on those levels: ABBV clearing $294.89 or losing $275.00; GILD clearing $174.48 or losing $153.51. Until one of them gives way, the relative reading above stands.